3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
8
Terminated
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
47
Squamous Cell Carcinoma of Head and Neck
19
Carcinoma, Non-Small-Cell Lung
15
Neoplasms
12
Head and Neck Neoplasms
9
Neoplasm Metastasis
8
Lung Neoplasms
8
Carcinoma, Squamous Cell
7
Pancreatic Neoplasms
6
Colonic Neoplasms
6
Solid Tumors
5
Rectal Neoplasms
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Gastrointestinal Neoplasms
3
Colorectal Cancer Metastatic
3
Carcinoma
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Melanoma
2
Locally Recurrent Rectal Cancer
2
Endometrial Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Pancreatic Ductal
2
Advanced Solid Tumor
2
Interventions
Nivolumab
11
Oxaliplatin
6
Fluorouracil
6
Capecitabine
5
pembrolizumab
4
Paclitaxel
4
Leucovorin
4
durvalumab
3
Radiotherapy
3
Folfox protocol
3
Drug Therapy
3
dehydroftorafur
2
Trastuzumab
2
Specimen Handling
2
Radiation
2
Metformin
2
Magnetic Resonance Spectroscopy
2
Itraconazole
2
Irinotecan
2
Docetaxel
2
Cisplatin
2
Carboplatin
2
zolbetuximab
1
zanidatamab
1
trifluridine tipiracil drug combination
1
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
pertuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Adenocarcinoma Of Esophagus
×
Cetuximab
×
Clear all
NCT05745857
2026-04-13
SLURP
University Medical Center Groningen
Phase 2
Recruiting
25 enrolled